Table: Brightpath Biotherapeutics - 6-MTH parent results

BrightPath Biotherapeutics Co

08/11/2024 06:37

Nov 8 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2024        Sep 30, 2023      Mar 31, 2025  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               0 mln             0 mln     
                 (+25.0 pct)         (-75.0 pct)       (-31.3 pct)  
  Operating     loss 542 mln        loss 550 mln      loss 925 mln  
  Recurring     loss 537 mln        loss 551 mln      loss 925 mln  
  Net           loss 538 mln        loss 553 mln      loss 927 mln  
  EPS           loss 7.11 yen       loss 8.81 yen    loss 13.08 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T